HEADER COMPLEX (PROTEINASE/INHIBITOR) 06-FEB-88 1SNI OBSLTE 07-SEP-88 1SNI 2SNI TITLE STRUCTURAL COMPARISONS OF TWO SERINE PROTEINASE(COLON) TITLE 2 *PROTEIN INHIBITOR COMPLEXES-EGLIN-C(COLON)*SUBTILISIN TITLE 3 CARLSBERG AND /CI$-2(COLON)*SUBTILISIN NOVO COMPND MOL_ID: 1; COMPND 2 MOLECULE:; COMPND 3 CHAIN: E; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE:; COMPND 7 CHAIN: I; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 MOL_ID: 2 KEYWDS COMPLEX (PROTEINASE/INHIBITOR) EXPDTA X-RAY DIFFRACTION AUTHOR C.A.MCPHALEN,M.N.G.JAMES REVDAT 2 07-SEP-88 1SNI 3 OBSLTE REVDAT 1 16-JUL-88 1SNI 0 JRNL AUTH C.A.MCPHALEN,M.N.G.JAMES JRNL TITL STRUCTURAL COMPARISONS OF TWO SERINE JRNL TITL 2 PROTEINASE(COLON)PROTEIN INHIBITOR JRNL TITL 3 COMPLEXES-EGLIN-C(COLON)SUBTILISIN CARLSBERG AND JRNL TITL 4 /CI-2(COLON)SUBTILISIN NOVO JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.A.MCPHALEN,M.N.G.JAMES REMARK 1 TITL CRYSTAL AND MOLECULAR STRUCTURE OF THE SERINE REMARK 1 TITL 2 PROTEINASE INHIBITOR /CI-2 FROM BARLEY SEEDS REMARK 1 REF BIOCHEMISTRY V. 26 261 1987 REMARK 1 REFN ASTM BICHAW US ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.A.MCPHALEN,I.SVENDSEN,I.JONASSEN,M.N.G.JAMES REMARK 1 TITL CRYSTAL AND MOLECULAR STRUCTURE OF CHYMOTRYPSIN REMARK 1 TITL 2 INHIBITOR 2 FROM BARLEY SEEDS IN COMPLEX WITH REMARK 1 TITL 3 SUBTILISIN NOVO REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 82 7242 1985 REMARK 1 REFN ASTM PNASA6 US ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. NULL ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2451 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 168 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SNI COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 1SNI THE ORDER OF THE FIRST FOUR RESIDUES OF CHAIN *I* IS REMARK 5 1SNI UNKNOWN. 1SNI REMARK 6 REMARK 6 1SNI SITE *ACT* IS THE ENZYME CATALYTIC SITE. SITES *IO1* REMARK 6 AND 1SNI *IO2* ARE ION BINDING SITES 1 AND 2, RESPECTIVELY. REMARK 6 THE 1SNI INHIBITOR REACTIVE SITE BOND IS LOCATED BETWEEN REMARK 6 RESIDUES 1SNI MET I 59 AND GLU I 60 (SITE *RSB*). 1SNI REMARK 7 REMARK 7 1SNI WATER MOLECULES WITH SEQUENCE NUMBERS 600 - 602 AND B REMARK 7 1SNI VALUES OF 0.0 WERE ADDED AT THE POSITIONS OF STRONG REMARK 7 PEAKS 1SNI IN THE FINAL DIFFERENCE MAP, AND THEIR POSITIONS REMARK 7 HAVE NOT 1SNI BEEN REFINED. 1SNI REMARK 8 REMARK 8 1SNI THE CROSS-OVER CONNECTION BETWEEN STRANDS 1 AND 2 OF REMARK 8 SHEET 1SNI S1E IS LEFT-HANDED. 1SNI REMARK 9 REMARK 9 1SNI THE BETA-SHEET OF THE INHIBITOR IS IRREGULAR , WITH REMARK 9 1SNI WELL-ORDERED WATER MOLECULES PROVIDING ALL BUT ONE REMARK 9 1SNI HYDROGEN-BONDING BRIDGE BETWEEN STRANDS 2 AND 3. SEE REMARK 9 THE 1SNI PAPER CITED ON THE *JRNL* RECORDS ABOVE. 1SNI REMARK 10 REMARK 10 1SNI CORRECTION. THIS ENTRY IS OBSOLETE. 07-SEP-88. 1SNI REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 1/2+X,1/2+Y,Z REMARK 290 4555 1/2-X,1/2+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 51.60000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.41500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 51.60000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.41500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLX I 1 REMARK 465 VAL I 2 REMARK 465 SER I 3 REMARK 465 SER I 4 REMARK 465 LYS I 5 REMARK 465 LYS I 6 REMARK 465 PRO I 7 REMARK 465 GLU I 8 REMARK 465 GLY I 9 REMARK 465 VAL I 10 REMARK 465 ASN I 11 REMARK 465 THR I 12 REMARK 465 GLY I 13 REMARK 465 ALA I 14 REMARK 465 GLY I 15 REMARK 465 ASP I 16 REMARK 465 ARG I 17 REMARK 465 HIS I 18 REMARK 465 ASN I 19 REMARK 525 REMARK 525 SOLVENT REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH 431 DISTANCE = 5.45 ANGSTROMS REMARK 525 HOH 432 DISTANCE = 7.09 ANGSTROMS REMARK 525 HOH 433 DISTANCE = 6.18 ANGSTROMS REMARK 525 HOH 436 DISTANCE = 12.16 ANGSTROMS REMARK 525 HOH 440 DISTANCE = 7.70 ANGSTROMS REMARK 525 HOH 446 DISTANCE = 5.51 ANGSTROMS REMARK 525 HOH 448 DISTANCE = 13.16 ANGSTROMS REMARK 525 HOH 452 DISTANCE = 7.61 ANGSTROMS REMARK 525 HOH 453 DISTANCE = 5.65 ANGSTROMS REMARK 525 HOH 455 DISTANCE = 7.29 ANGSTROMS REMARK 525 HOH 456 DISTANCE = 13.23 ANGSTROMS REMARK 525 HOH 466 DISTANCE = 5.74 ANGSTROMS REMARK 525 HOH 468 DISTANCE = 5.50 ANGSTROMS REMARK 525 HOH 478 DISTANCE = 5.21 ANGSTROMS REMARK 525 HOH 479 DISTANCE = 5.77 ANGSTROMS REMARK 525 HOH 490 DISTANCE = 6.94 ANGSTROMS REMARK 525 HOH 497 DISTANCE = 5.05 ANGSTROMS REMARK 525 HOH 498 DISTANCE = 8.41 ANGSTROMS REMARK 525 HOH 506 DISTANCE = 7.87 ANGSTROMS SEQRES 1 E 275 ALA GLN SER VAL PRO TYR GLY VAL SER GLN ILE LYS ALA SEQRES 2 E 275 PRO ALA LEU HIS SER GLN GLY TYR THR GLY SER ASN VAL SEQRES 3 E 275 LYS VAL ALA VAL ILE ASP SER GLY ILE ASP SER SER HIS SEQRES 4 E 275 PRO ASP LEU LYS VAL ALA GLY GLY ALA SER MET VAL PRO SEQRES 5 E 275 SER GLU THR ASN PRO PHE GLN ASP ASN ASN SER HIS GLY SEQRES 6 E 275 THR HIS VAL ALA GLY THR VAL ALA ALA LEU ASN ASN SER SEQRES 7 E 275 ILE GLY VAL LEU GLY VAL ALA PRO SER ALA SER LEU TYR SEQRES 8 E 275 ALA VAL LYS VAL LEU GLY ALA ASP GLY SER GLY GLN TYR SEQRES 9 E 275 SER TRP ILE ILE ASN GLY ILE GLU TRP ALA ILE ALA ASN SEQRES 10 E 275 ASN MET ASP VAL ILE ASN MET SER LEU GLY GLY PRO SER SEQRES 11 E 275 GLY SER ALA ALA LEU LYS ALA ALA VAL ASP LYS ALA VAL SEQRES 12 E 275 ALA SER GLY VAL VAL VAL VAL ALA ALA ALA GLY ASN GLU SEQRES 13 E 275 GLY THR SER GLY SER SER SER THR VAL GLY TYR PRO GLY SEQRES 14 E 275 LYS TYR PRO SER VAL ILE ALA VAL GLY ALA VAL ASP SER SEQRES 15 E 275 SER ASN GLN ARG ALA SER PHE SER SER VAL GLY PRO GLU SEQRES 16 E 275 LEU ASP VAL MET ALA PRO GLY VAL SER ILE GLN SER THR SEQRES 17 E 275 LEU PRO GLY ASN LYS TYR GLY ALA TYR ASN GLY THR SER SEQRES 18 E 275 MET ALA SER PRO HIS VAL ALA GLY ALA ALA ALA LEU ILE SEQRES 19 E 275 LEU SER LYS HIS PRO ASN TRP THR ASN THR GLN VAL ARG SEQRES 20 E 275 SER SER LEU GLN ASN THR THR THR LYS LEU GLY ASP SER SEQRES 21 E 275 PHE TYR TYR GLY LYS GLY LEU ILE ASN VAL GLN ALA ALA SEQRES 22 E 275 ALA GLN SEQRES 1 I 83 GLX VAL SER SER LYS LYS PRO GLU GLY VAL ASN THR GLY SEQRES 2 I 83 ALA GLY ASP ARG HIS ASN LEU LYS THR GLU TRP PRO GLU SEQRES 3 I 83 LEU VAL GLY LYS SER VAL GLU GLU ALA LYS LYS VAL ILE SEQRES 4 I 83 LEU GLN ASP LYS PRO GLU ALA GLN ILE ILE VAL LEU PRO SEQRES 5 I 83 VAL GLY THR ILE VAL THR MET GLU TYR ARG ILE ASP ARG SEQRES 6 I 83 VAL ARG LEU PHE VAL ASP LYS LEU ASP ASN ILE ALA GLU SEQRES 7 I 83 VAL PRO ARG VAL GLY FTNOTE 1 SEE REMARK 7. FTNOTE 2 RESIDUE CYS E 168 IS A CIS PROLINE. HET CA E 1 1 HET CA E 2 1 HETNAM CA CALCIUM ION FORMUL 3 CA 2(CA 2+) FORMUL 5 HOH *168(H2 O1) HELIX 1 EA TYR E 6 ILE E 11 1 6 HELIX 2 EB ALA E 13 SER E 18 1 6 HELIX 3 EC SER E 63 ALA E 74 1 12 HELIX 4 ED GLN E 103 ASN E 117 1 15 HELIX 5 EE SER E 132 SER E 145 1 14 HELIX 6 EF THR E 220 HIS E 238 1INTERRUPTED BY PRO 225 19 HELIX 7 EG THR E 242 ASN E 252 1 11 HELIX 8 EH ASP E 259 GLY E 264 1 6 HELIX 9 EI ASN E 269 ALA E 274 1 6 HELIX 10 IA SER I 31 LYS I 43 1 13 SHEET 1 S1E 7 GLY E 46 MET E 50 0 SHEET 2 S1E 7 SER E 89 VAL E 95 1 N ALA E 92 O GLY E 46 SHEET 3 S1E 7 VAL E 26 ASP E 32 1 N ASP E 32 O VAL E 93 SHEET 4 S1E 7 ASP E 120 MET E 124 1 O VAL E 121 N ALA E 29 SHEET 5 S1E 7 VAL E 148 ALA E 153 1 O VAL E 148 N ILE E 122 SHEET 6 S1E 7 ILE E 175 VAL E 180 1 N ILE E 175 O VAL E 149 SHEET 7 S1E 7 VAL E 198 GLY E 202 1 O VAL E 198 N GLY E 178 SHEET 1 S2E 2 ILE E 205 LEU E 209 0 SHEET 2 S2E 2 LYS E 213 TYR E 217 -1 O TYR E 217 N ILE E 205 SHEET 1 S1I 4 THR I 22 TRP I 24 0 SHEET 2 S1I 4 PRO I 80 VAL I 82 -1 N VAL I 82 O THR I 22 SHEET 3 S1I 4 ASP I 64 VAL I 70 -1 SHEET 4 S1I 4 GLN I 47 VAL I 53 1 N GLN I 47 O ASP I 64 TURN 1 1E SER E 9 LYS E 12 TYPE I TURN 2 2E ALA E 13 LEU E 16 TYPE III TURN 3 3E LEU E 16 GLN E 19 TYPE III TURN 4 4E HIS E 17 GLY E 20 TYPE I TURN 5 5E GLY E 23 VAL E 26 TYPE II TURN 6 6E ASP E 36 HIS E 39 TYPE I TURN 7 7E HIS E 39 LEU E 42 TYPE I TURN 8 8E VAL E 51 GLU E 54 TYPE I TURN 9 9E ALA E 85 ALA E 88 TYPE I TURN 10 10E GLY E 97 GLY E 100 TYPE I TURN 11 11E GLN E 103 TRP E 106 TYPE III TURN 12 12E ILE E 115 ASN E 118 TYPE I TURN 13 13E VAL E 143 GLY E 146 TYPE I TURN 14 14E SER E 159 SER E 162 TYPE II(PRIME) TURN 15 15E PRO E 168 TYR E 171 TYPE III TURN 16 16E TYR E 171 VAL E 174 TYPE I TURN 17 17E ASP E 181 ASN E 184 TYPE I TURN 18 18E ALA E 187 SER E 190 TYPE I TURN 19 19E GLY E 193 LEU E 196 TYPE I TURN 20 20E GLY E 219 MET E 222 TYPE III TURN 21 21E ALA E 223 HIS E 226 TYPE III TURN 22 22E SER E 224 VAL E 227 TYPE III TURN 23 23E HIS E 238 TRP E 241 TYPE I TURN 24 24E ASP E 259 TYR E 262 TYPE III TURN 25 25E TYR E 263 GLY E 266 TYPE II(PRIME) TURN 26 26E ALA E 272 GLN E 275 TYPE I TURN 27 1I TRP I 24 LEU I 27 TYPE III TURN 28 2I LEU I 27 LYS I 30 TYPE II TURN 29 3I LYS I 43 ALA I 46 TYPE I TURN 30 4I ARG I 62 ARG I 65 TYPE I TURN 31 5I ASP I 71 ASP I 74 TYPE I CISPEP 1 TYR E 167 PRO E 168 0 1.09 SITE 1 ACT 3 ASP E 32 HIS E 64 SER E 221 SITE 1 IO1 6 GLN E 2 ASP E 41 LEU E 75 ASN E 77 SITE 2 IO1 6 ILE E 79 VAL E 81 SITE 1 IO2 6 GLY E 169 TYR E 171 VAL E 174 GLU E 195 SITE 2 IO2 6 ASP E 197 HOH 391 SITE 1 RSB 2 MET I 59 GLU I 60 CRYST1 103.200 56.830 68.700 90.00 127.40 90.00 C 1 2 1 4 ORIGX1 0.009690 0.000000 0.007409 0.00000 ORIGX2 0.000000 0.017596 0.000000 0.00000 ORIGX3 0.000000 0.000000 0.018323 0.00000 SCALE1 0.009690 0.000000 0.007409 0.00000 SCALE2 0.000000 0.017596 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018323 0.00000